发明名称 Enamine derivatives
摘要 Enamine derivatives of formula (1) are described:whereinR<1 >is a group Ar<1>L<2>Ar<2>Alk- in, which Ar<1 >is an aromatic or heteroaromatic group, L<2 >is a covalent bond or a linker atom or group, Ar<2 >is an arylene or heteroarylene group and Alk is a chain -CH2-CH(R)-, -CH=C(R)- orin which R is a carboxylic acid or a derivative or biostere thereof;R<2 >is a hydrogen atom or a C1-6alkyl group;Cy is a cycloaliphatic or heterocycloaliphatic ring in which X is a N atom or a C(R<w>) group;R<x >is a oxo, thioxo, or imino group;R<w >and R<z >is each a hydrogen atom or optional substituent; provided that Cy is not a cyclobutenedione group; and the salts, solvates, hydrates and N-oxides thereof.The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells.
申请公布号 AU4855301(A) 申请公布日期 2001.10.30
申请号 AU20010048553 申请日期 2001.04.12
申请人 CELLTECH R AND D LIMITED 发明人 TIMOTHY JOHN NORMAN;JOHN ROBERT PORTER;BRIAN WOODSIDE HUTCHINSON;ANDREW JAMES RATCLIFFE;JOHN CLIFFORD HEAD;RIKKI PETER ALEXANDER;BARRY JOHN LANGHAM;GRAHAM JOHN WARRELLOW;SARAH CATHERINE ARCHIBALD;JANEEN MARSHA LINSLEY
分类号 A61K31/198;A61K31/223;A61K31/4375;A61K31/4409;A61K31/4436;A61K31/4545;A61K31/472;A61P1/04;A61P3/10;A61P11/06;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P25/28;A61P29/00;A61P37/06;A61P43/00;C07C229/36;C07D213/81;C07D217/22;C07D409/12;C07D471/04 主分类号 A61K31/198
代理机构 代理人
主权项
地址